/Investor DB

FACIT (Fight Against Cancer Innovation Trust) — 2022 Investments

1 investments dated 2022 · listed companies and verified rows first · show all

Xpan Incxpanmedical.comin𝕏Aug 2022

Xpan develops a single universal trocar for minimally invasive surgery (MIS) that accommodates all surgical instruments, aiming to replace traditional trocar access.

BiotechHardwareHealthtechMedical DevicesNobleton

Suresh Pai(Co-Founder & Board Director)inZaid Atto(Founder & CEO)in

Co-investorsUniversity of Toronto Entrepreneurship Hatchery

Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.